Pages that link to "Q31109560"
Jump to navigation
Jump to search
The following pages link to Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis (Q31109560):
Displaying 50 items.
- A Precision Medicine Initiative for Alzheimer's disease: the road ahead to biomarker-guided integrative disease modeling (Q30235315) (← links)
- Exercise induces cerebral VEGF and angiogenesis via the lactate receptor HCAR1 (Q30854541) (← links)
- Early neurovascular dysfunction in a transgenic rat model of Alzheimer's disease (Q33555571) (← links)
- Cerebral Microvascular Accumulation of Tau Oligomers in Alzheimer's Disease and Related Tauopathies (Q33714234) (← links)
- Application of calibrated fMRI in Alzheimer's disease (Q33726147) (← links)
- Neuroimaging tests for clinical psychiatry: Are we there yet? (Q33842681) (← links)
- Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers (Q34682521) (← links)
- Taxifolin inhibits amyloid-β oligomer formation and fully restores vascular integrity and memory in cerebral amyloid angiopathy (Q36335013) (← links)
- Advances in arterial spin labelling MRI methods for measuring perfusion and collateral flow. (Q36396660) (← links)
- Alzheimer's disease severity, objectively determined and measured (Q37363931) (← links)
- Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer's pathology. (Q37396195) (← links)
- Macrovascular and microvascular cerebral blood flow in adults at risk for Alzheimer's disease (Q37654110) (← links)
- MRI assessment of whole-brain structural changes in aging (Q38604991) (← links)
- Pericortical Enhancement on Delayed Postgadolinium Fluid-Attenuated Inversion Recovery Images in Normal Aging, Mild Cognitive Impairment, and Alzheimer Disease (Q38661720) (← links)
- Plasma cytokine IL-6 levels and subjective cognitive decline: preliminary findings. (Q38668100) (← links)
- The Cognitive decline in Older Patients with End stage renal disease (COPE) study - rationale and design. (Q38730795) (← links)
- Early-onset and delayed-onset poststroke dementia - revisiting the mechanisms. (Q38756224) (← links)
- Brain Perivascular Macrophages Initiate the Neurovascular Dysfunction of Alzheimer Aβ Peptides. (Q38780279) (← links)
- Hypoxia/ischemia activate processing of Amyloid Precursor Protein: impact of vascular dysfunction in the pathogenesis of Alzheimer's disease (Q39041998) (← links)
- Detectable Neuropsychological Differences in Early Preclinical Alzheimer's Disease: A Meta-Analysis (Q39301541) (← links)
- Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease (Q39313671) (← links)
- A clinicopathological approach to the diagnosis of dementia (Q39434968) (← links)
- Rho-associated protein kinases as therapeutic targets for both vascular and parenchymal pathologies in Alzheimer's disease. (Q39444002) (← links)
- Intracranial IL-17A overexpression decreases cerebral amyloid angiopathy by upregulation of ABCA1 in an animal model of Alzheimer's disease. (Q40193607) (← links)
- Impaired hypoxic tolerance in APP23 mice: a dysregulation of neuroprotective globin levels (Q42334782) (← links)
- 'Alzheimer's Progression Score': Development of a Biomarker Summary Outcome for AD Prevention Trials (Q42376619) (← links)
- Microvascular ultrastructural changes precede cognitive impairment in the murine APPswe/PS1dE9 model of Alzheimer's disease (Q43249667) (← links)
- Validation of T1w-based segmentations of white matter hyperintensity volumes in large-scale datasets of aging. (Q45942978) (← links)
- Alzheimer's disease: A matter of blood-brain barrier dysfunction? (Q46165463) (← links)
- Concordance Between Cerebrospinal Fluid Biomarkers with Alzheimer's Disease Pathology Between Three Independent Assay Platforms (Q46254853) (← links)
- Angiotensin IV Receptors Mediate the Cognitive and Cerebrovascular Benefits of Losartan in a Mouse Model of Alzheimer's Disease (Q46370959) (← links)
- Cerebrovascular resistance: effects on cognitive decline, cortical atrophy, and progression to dementia (Q46398713) (← links)
- Using simultaneous PET/MRI to compare the accuracy of diagnosing frontotemporal dementia by arterial spin labelling MRI and FDG-PET. (Q47096954) (← links)
- Alpha-2 macroglobulin in Alzheimer's disease: a marker of neuronal injury through the RCAN1 pathway. (Q47201004) (← links)
- Pericyte implantation in the brain enhances cerebral blood flow and reduces amyloid-β pathology in amyloid model mice. (Q47437348) (← links)
- Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders (Q47707801) (← links)
- Multiscale modelling of blood flow in cerebral microcirculation: Details at capillary scale control accuracy at the level of the cortex (Q47737999) (← links)
- Endothelial LRP1 - A Potential Target for the Treatment of Alzheimer's Disease : Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla. (Q47743028) (← links)
- Vitamin D and the Risk of Dementia: The Rotterdam Study (Q47747850) (← links)
- Enhancement of automated blood flow estimates (ENABLE) from arterial spin-labeled MRI. (Q47775881) (← links)
- A Perfect sTORm: The Role of the Mammalian Target of Rapamycin (mTOR) in Cerebrovascular Dysfunction of Alzheimer's Disease: A Mini-Review (Q47872250) (← links)
- Detrimental effect of systemic vascular risk factors on brain hemodynamic function assessed with MRI. (Q47872692) (← links)
- Classification of Depression, Cognitive Disorders, and Co-Morbid Depression and Cognitive Disorders with Perfusion SPECT Neuroimaging (Q47966683) (← links)
- Cerebral blood flow in normal aging adults: cardiovascular determinants, clinical implications, and aerobic fitness (Q48029820) (← links)
- Cerebral hypoperfusion is not associated with an increase in amyloid β pathology in middle-aged or elderly people. (Q48190450) (← links)
- Early-stage attenuation of phase-amplitude coupling in the hippocampus and medial prefrontal cortex in a transgenic rat model of Alzheimer's disease (Q48289308) (← links)
- Revising the ICD: stroke is a brain disease (Q48474821) (← links)
- Aminopyrimidine Class Aggregation Inhibitor Effectively Blocks Aβ-Fibrinogen Interaction and Aβ-Induced Contact System Activation. (Q49374917) (← links)
- Impacts of Metabolic Syndrome Scores on Cerebrovascular Conductance Are Mediated by Arterial Stiffening (Q49384560) (← links)
- Mathematical Modeling of Protein Misfolding Mechanisms in Neurological Diseases: A Historical Overview (Q49477647) (← links)